Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 5
2005 5
2006 2
2007 6
2008 5
2009 1
2010 8
2011 6
2012 6
2013 10
2014 7
2015 7
2016 11
2017 4
2018 11
2019 7
2020 11
2021 5
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

120 results

Results by year

Filters applied: . Clear all
Page 1
Caloric restriction and metformin selectively improved LKB1-mutated NSCLC tumor response to chemo- and chemo-immunotherapy.
Ndembe G, Intini I, Moro M, Grasselli C, Panfili A, Panini N, Bleve A, Occhipinti M, Borzi C, Garassino MC, Marabese M, Canesi S, Scanziani E, Sozzi G, Broggini M, Ganzinelli M. Ndembe G, et al. Among authors: broggini m. J Exp Clin Cancer Res. 2024 Jan 2;43(1):6. doi: 10.1186/s13046-023-02933-5. J Exp Clin Cancer Res. 2024. PMID: 38163906 Free PMC article.
Editorial: Patient-derived tumor models for drug development.
Sabaawy HE, Broggini M, Gupta SK. Sabaawy HE, et al. Among authors: broggini m. Front Oncol. 2023 Jul 7;13:1243534. doi: 10.3389/fonc.2023.1243534. eCollection 2023. Front Oncol. 2023. PMID: 37483498 Free PMC article. No abstract available.
Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles.
Gustà MF, Edel MJ, Salazar VA, Alvarez-Palomo B, Juan M, Broggini M, Damia G, Bigini P, Corbelli A, Fiordaliso F, Barbul A, Korenstein R, Bastús NG, Puntes V. Gustà MF, et al. Among authors: broggini m. Front Immunol. 2023 May 9;14:1128582. doi: 10.3389/fimmu.2023.1128582. eCollection 2023. Front Immunol. 2023. PMID: 37228592 Free PMC article.
The EU-funded I3LUNG Project: Integrative Science, Intelligent Data Platform for Individualized LUNG Cancer Care With Immunotherapy.
Prelaj A, Ganzinelli M, Trovo' F, Roisman LC, Pedrocchi ALG, Kosta S, Restelli M, Ambrosini E, Broggini M, Pravettoni G, Monzani D, Nuara A, Amat R, Spathas N, Willis M, Pearson A, Dolezal J, Mazzeo L, Sangaletti S, Correa AM, Aguaron A, Watermann I, Popa C, Raimondi G, Triulzi T, Steurer S, Lo Russo G, Linardou H, Peled N, Felip E, Reck M, Garassino MC. Prelaj A, et al. Among authors: broggini m. Clin Lung Cancer. 2023 Jun;24(4):381-387. doi: 10.1016/j.cllc.2023.02.005. Epub 2023 Feb 28. Clin Lung Cancer. 2023. PMID: 36959048
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies.
Mendogni P, Affatato R, Cabri E, Chiappa M, Ndembe G, Tosi D, Del Gobbo A, Fratelli M, Pardini E, Petrini I, Rosso L, Broggini M, Marabese M. Mendogni P, et al. Among authors: broggini m. J Exp Clin Cancer Res. 2022 Dec 14;41(1):343. doi: 10.1186/s13046-022-02554-4. J Exp Clin Cancer Res. 2022. PMID: 36517829 Free PMC article.
Present and Future Perspective on PLK1 Inhibition in Cancer Treatment.
Chiappa M, Petrella S, Damia G, Broggini M, Guffanti F, Ricci F. Chiappa M, et al. Among authors: broggini m. Front Oncol. 2022 Jun 2;12:903016. doi: 10.3389/fonc.2022.903016. eCollection 2022. Front Oncol. 2022. PMID: 35719948 Free PMC article. Review.
LKB1: Can We Target an Hidden Target? Focus on NSCLC.
Ndembe G, Intini I, Perin E, Marabese M, Caiola E, Mendogni P, Rosso L, Broggini M, Colombo M. Ndembe G, et al. Among authors: broggini m. Front Oncol. 2022 May 11;12:889826. doi: 10.3389/fonc.2022.889826. eCollection 2022. Front Oncol. 2022. PMID: 35646638 Free PMC article. Review.
The integrated stress response is tumorigenic and constitutes a therapeutic liability in KRAS-driven lung cancer.
Ghaddar N, Wang S, Woodvine B, Krishnamoorthy J, van Hoef V, Darini C, Kazimierczak U, Ah-Son N, Popper H, Johnson M, Officer L, Teodósio A, Broggini M, Mann KK, Hatzoglou M, Topisirovic I, Larsson O, Le Quesne J, Koromilas AE. Ghaddar N, et al. Among authors: broggini m. Nat Commun. 2021 Jul 30;12(1):4651. doi: 10.1038/s41467-021-24661-0. Nat Commun. 2021. PMID: 34330898 Free PMC article.
120 results